Vanda Pharmaceuticals (VNDA) Cash & Equivalents Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -51.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.67% |
| Dec 31, 2025 | -17.07% |
| Sep 30, 2025 | -30.32% |
| Jun 30, 2025 | -21.34% |
| Mar 31, 2025 | -10.68% |
| Dec 31, 2024 | -24.67% |
| Sep 30, 2024 | -45.14% |
| Jun 30, 2024 | -31.38% |
| Mar 31, 2024 | -64.66% |
| Dec 31, 2023 | 0.59% |
| Sep 30, 2023 | 270.84% |
| Jun 30, 2023 | 157.67% |
| Mar 31, 2023 | 429.19% |
| Dec 31, 2022 | 159.32% |
| Sep 30, 2022 | -2.23% |
| Jun 30, 2022 | 1.72% |
| Mar 31, 2022 | -7.22% |
| Dec 31, 2021 | -14.68% |
| Sep 30, 2021 | -11.32% |
| Jun 30, 2021 | -39.94% |
| Mar 31, 2021 | 11.06% |
| Dec 31, 2020 | 35.41% |
| Sep 30, 2020 | 45.31% |
| Jun 30, 2020 | 104.77% |
| Mar 31, 2020 | 88.92% |
| Dec 31, 2019 | -26.12% |
| Sep 30, 2019 | -35.49% |
| Jun 30, 2019 | -23.56% |
| Mar 31, 2019 | -77.86% |
| Dec 31, 2018 | 81.42% |
| Sep 30, 2018 | 169.10% |
| Jun 30, 2018 | 327.85% |
| Mar 31, 2018 | 672.18% |
| Dec 31, 2017 | -66.68% |
| Sep 30, 2017 | -31.07% |
| Jun 30, 2017 | -38.64% |
| Mar 31, 2017 | -48.09% |
| Dec 31, 2016 | 98.48% |
| Sep 30, 2016 | -29.97% |
| Jun 30, 2016 | -52.02% |
| Mar 31, 2016 | 18.08% |
| Dec 31, 2015 | -16.52% |
| Sep 30, 2015 | 205.63% |
| Jun 30, 2015 | 184.44% |
| Mar 31, 2015 | -24.16% |
| Dec 31, 2014 | -5.96% |
| Sep 30, 2014 | -89.23% |
| Jun 30, 2014 | -83.60% |
| Mar 31, 2014 | -60.65% |
| Dec 31, 2013 | -27.04% |
| Sep 30, 2013 | 36.03% |
| Jun 30, 2013 | 9.79% |
| Mar 31, 2013 | 1.70% |
| Dec 31, 2012 | 0.97% |
| Sep 30, 2012 | 73.25% |
| Jun 30, 2012 | 87.33% |
| Mar 31, 2012 | 105.81% |
| Dec 31, 2011 | 106.59% |
| Sep 30, 2011 | -41.13% |
| Jun 30, 2011 | -65.41% |
| Dec 31, 2010 | -79.27% |